Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-25 @ 5:19 AM
NCT ID:
NCT01364727
Brief Title:
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Official Title:
A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Study:
NCT01364727
Protocol Section:
NCT01364727